Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Chimeric Antigen Receptor Cell Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Hebei Senlang Biotechnology Inc Ltd
Bellicum Pharmaceuticals Inc
Sorrento Therapeutics Inc
Beijing Immunochina Medical Science & Technology Co Ltd
Celyad SA
Novartis AG
Cell Medica Ltd
Celgene Corp
Fosun Pharmaceutical AG
Kite Pharma Inc
NantKwest Inc
Gilead Sciences Inc
Bristol-Myers Squibb Co
Juno Therapeutics Inc
Celularity Inc
Cellular Biomedicine Group Inc
Amgen Inc
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Nanjing Legend Biotech Co Ltd
Nkarta Inc
Autolus Therapeutics Plc
HRAIN Biotechnology Co Ltd
bluebird bio Inc
Daiichi Sankyo Co Ltd
Ono Pharmaceutical Co Ltd
Takara Bio Inc
By Type:
Monotherapy
Combination Therapy
By Application:
Transplant Rejection
Other
Acute Leukemia
Multiple Myeloma
Non-hodgkin's Lymphoma
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Chimeric Antigen Receptor Cell Therapy Market Overview 2018-2029
-
1.1 China Chimeric Antigen Receptor Cell Therapy Industry Development Overview
-
1.2 China Chimeric Antigen Receptor Cell Therapy Industry Development History
-
1.3 China Chimeric Antigen Receptor Cell Therapy Industry Market Size (2018-2029)
-
1.4 China Chimeric Antigen Receptor Cell Therapy Market Analysis by Type from Production Side
-
1.4.1 China Chimeric Antigen Receptor Cell Therapy Production Volume, Production Value and Growth Rate of Monotherapy (2018-2029)
-
1.4.2 China Chimeric Antigen Receptor Cell Therapy Production Volume, Production Value and Growth Rate of Combination Therapy (2018-2029)
-
1.5 China Chimeric Antigen Receptor Cell Therapy Market Analysis by Application from Consumption End
-
1.5.1 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Transplant Rejection (2018-2029)
-
1.5.2 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.3 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Acute Leukemia (2018-2029)
-
1.5.4 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Multiple Myeloma (2018-2029)
-
1.5.5 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Non-hodgkin's Lymphoma (2018-2029)
-
1.6 China Chimeric Antigen Receptor Cell Therapy Market Analysis by Region
-
1.6.1 North China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Chimeric Antigen Receptor Cell Therapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Chimeric Antigen Receptor Cell Therapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Chimeric Antigen Receptor Cell Therapy Market Status and Competition Analysis in 2023
-
2.2.3 China Chimeric Antigen Receptor Cell Therapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Chimeric Antigen Receptor Cell Therapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Chimeric Antigen Receptor Cell Therapy Industry Development
Chapter 3 Chimeric Antigen Receptor Cell TherapyIndustry Chain Analysis
-
3.1 Chimeric Antigen Receptor Cell Therapy Industry Chain
-
3.2 Chimeric Antigen Receptor Cell Therapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Chimeric Antigen Receptor Cell Therapy Market
-
3.3 Chimeric Antigen Receptor Cell Therapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Chimeric Antigen Receptor Cell Therapy Market
Chapter 4 China Chimeric Antigen Receptor Cell Therapy Market, by Type
-
4.1 China Chimeric Antigen Receptor Cell Therapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Chimeric Antigen Receptor Cell Therapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Chimeric Antigen Receptor Cell Therapy Production Volume and Growth Rate, by Type
-
4.5.1 China Chimeric Antigen Receptor Cell Therapy Production Volume and Growth Rate of Monotherapy
-
4.5.2 China Chimeric Antigen Receptor Cell Therapy Production Volume and Growth Rate of Combination Therapy
Chapter 5 China Chimeric Antigen Receptor Cell Therapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Chimeric Antigen Receptor Cell Therapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate, by Application
-
5.5.1 China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Transplant Rejection
-
5.5.2 China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Other
-
5.5.3 China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Acute Leukemia
-
5.5.4 China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Multiple Myeloma
-
5.5.5 China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Non-hodgkin's Lymphoma
Chapter 6 China Chimeric Antigen Receptor Cell Therapy Market, by Region
-
6.1 China Chimeric Antigen Receptor Cell Therapy Production Volume and Production Value, by Region
-
6.2 China Chimeric Antigen Receptor Cell Therapy Sales Volume and Sales Value, by Region
Chapter 7 North China Chimeric Antigen Receptor Cell Therapy Market Analysis
-
7.1 North China Chimeric Antigen Receptor Cell Therapy Market, by Type
-
7.2 North China Chimeric Antigen Receptor Cell Therapy Market, by Application
Chapter 8 Central China Chimeric Antigen Receptor Cell Therapy Market Analysis
-
8.1 Central China Chimeric Antigen Receptor Cell Therapy Market, by Type
-
8.2 Central China Chimeric Antigen Receptor Cell Therapy Market, by Application
Chapter 9 South China Chimeric Antigen Receptor Cell Therapy Market Analysis
-
9.1 South China Chimeric Antigen Receptor Cell Therapy Market, by Type
-
9.2 South China Chimeric Antigen Receptor Cell Therapy Market, by Application
Chapter 10 East China Chimeric Antigen Receptor Cell Therapy Market Analysis
-
10.1 East China Chimeric Antigen Receptor Cell Therapy Market, by Type
-
10.2 East China Chimeric Antigen Receptor Cell Therapy Market, by Application
Chapter 11 Northeast China Chimeric Antigen Receptor Cell Therapy Market Analysis
-
11.1 Northeast China Chimeric Antigen Receptor Cell Therapy Market, by Type
-
11.2 Northeast China Chimeric Antigen Receptor Cell Therapy Market, by Application
Chapter 12 Southwest China Chimeric Antigen Receptor Cell Therapy Market Analysis
-
12.1 Southwest China Chimeric Antigen Receptor Cell Therapy Market, by Type
-
12.2 Southwest China Chimeric Antigen Receptor Cell Therapy Market, by Application
Chapter 13 Northwest China Chimeric Antigen Receptor Cell Therapy Market Analysis
-
13.1 Northwest China Chimeric Antigen Receptor Cell Therapy Market, by Type
-
13.2 Northwest China Chimeric Antigen Receptor Cell Therapy Market, by Application
Chapter 14 Company Profiles
-
14.1 Hebei Senlang Biotechnology Inc Ltd
-
14.1.1 Hebei Senlang Biotechnology Inc Ltd Company Profile
-
14.1.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Bellicum Pharmaceuticals Inc
-
14.2.1 Bellicum Pharmaceuticals Inc Company Profile
-
14.2.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sorrento Therapeutics Inc
-
14.3.1 Sorrento Therapeutics Inc Company Profile
-
14.3.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Beijing Immunochina Medical Science & Technology Co Ltd
-
14.4.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Profile
-
14.4.2 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Celyad SA
-
14.5.1 Celyad SA Company Profile
-
14.5.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Profile
-
14.6.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Cell Medica Ltd
-
14.7.1 Cell Medica Ltd Company Profile
-
14.7.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Celgene Corp
-
14.8.1 Celgene Corp Company Profile
-
14.8.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Fosun Pharmaceutical AG
-
14.9.1 Fosun Pharmaceutical AG Company Profile
-
14.9.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Kite Pharma Inc
-
14.10.1 Kite Pharma Inc Company Profile
-
14.10.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 NantKwest Inc
-
14.11.1 NantKwest Inc Company Profile
-
14.11.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Gilead Sciences Inc
-
14.12.1 Gilead Sciences Inc Company Profile
-
14.12.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Bristol-Myers Squibb Co
-
14.13.1 Bristol-Myers Squibb Co Company Profile
-
14.13.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Juno Therapeutics Inc
-
14.14.1 Juno Therapeutics Inc Company Profile
-
14.14.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Celularity Inc
-
14.15.1 Celularity Inc Company Profile
-
14.15.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Cellular Biomedicine Group Inc
-
14.16.1 Cellular Biomedicine Group Inc Company Profile
-
14.16.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Amgen Inc
-
14.17.1 Amgen Inc Company Profile
-
14.17.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
-
14.18.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Profile
-
14.18.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 Nanjing Legend Biotech Co Ltd
-
14.19.1 Nanjing Legend Biotech Co Ltd Company Profile
-
14.19.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.19.3 Product&Service Introduction
-
14.20 Nkarta Inc
-
14.20.1 Nkarta Inc Company Profile
-
14.20.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.20.3 Product&Service Introduction
-
14.21 Autolus Therapeutics Plc
-
14.21.1 Autolus Therapeutics Plc Company Profile
-
14.21.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.21.3 Product&Service Introduction
-
14.22 HRAIN Biotechnology Co Ltd
-
14.22.1 HRAIN Biotechnology Co Ltd Company Profile
-
14.22.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.22.3 Product&Service Introduction
-
14.23 bluebird bio Inc
-
14.23.1 bluebird bio Inc Company Profile
-
14.23.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.23.3 Product&Service Introduction
-
14.24 Daiichi Sankyo Co Ltd
-
14.24.1 Daiichi Sankyo Co Ltd Company Profile
-
14.24.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.24.3 Product&Service Introduction
-
14.25 Ono Pharmaceutical Co Ltd
-
14.25.1 Ono Pharmaceutical Co Ltd Company Profile
-
14.25.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.25.3 Product&Service Introduction
-
14.26 Takara Bio Inc
-
14.26.1 Takara Bio Inc Company Profile
-
14.26.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Market Performance
-
14.26.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Chimeric Antigen Receptor Cell Therapy Industry Research Conclusions
-
15.2 Chimeric Antigen Receptor Cell Therapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Chimeric Antigen Receptor Cell Therapy Industry Market Size (2018-2029)
-
Figure China Chimeric Antigen Receptor Cell Therapy Production Volume, Production Value and Growth Rate of Monotherapy (2018-2029)
-
Figure China Chimeric Antigen Receptor Cell Therapy Production Volume, Production Value and Growth Rate of Combination Therapy (2018-2029)
-
Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Transplant Rejection (2018-2029)
-
Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Acute Leukemia (2018-2029)
-
Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Multiple Myeloma (2018-2029)
-
Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate of Non-hodgkin's Lymphoma (2018-2029)
-
Figure North China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
Figure South China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
Figure East China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2018-2029
-
Figure Chimeric Antigen Receptor Cell Therapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Share by Type in 2018
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Share by Type in 2023
-
Figure China Chimeric Antigen Receptor Cell Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Production Volume and Growth Rate of Monotherapy (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Production Volume and Growth Rate of Combination Therapy (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Share by Application in 2018
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Share by Application in 2023
-
Figure China Chimeric Antigen Receptor Cell Therapy Total Market Size and Growth Rate from Consumption End
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Transplant Rejection (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Other (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Acute Leukemia (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Multiple Myeloma (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Non-hodgkin's Lymphoma (2018-2023)
-
Table China Chimeric Antigen Receptor Cell Therapy Production Volume by Region (2018-2023)
-
Table China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Region (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Region (2018-2023)
-
Table China Chimeric Antigen Receptor Cell Therapy Production Value by Region (2018-2023)
-
Table China Chimeric Antigen Receptor Cell Therapy Production Value Share by Region (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Production Value Share by Region (2018-2023)
-
Table China Chimeric Antigen Receptor Cell Therapy Sales Volume by Region (2018-2023)
-
Table China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Region (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Region (2018-2023)
-
Table China Chimeric Antigen Receptor Cell Therapy Sales Value by Region (2018-2023)
-
Table China Chimeric Antigen Receptor Cell Therapy Sales Value Share by Region (2018-2023)
-
Figure China Chimeric Antigen Receptor Cell Therapy Sales Value Share by Region (2018-2023)
-
Table North China Chimeric Antigen Receptor Cell Therapy Production Volume by Type (2018-2023)
-
Table North China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Figure North China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Table North China Chimeric Antigen Receptor Cell Therapy Sales Volume by Application (2018-2023)
-
Table North China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Figure North China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Table Central China Chimeric Antigen Receptor Cell Therapy Production Volume by Type (2018-2023)
-
Table Central China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Figure Central China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Table Central China Chimeric Antigen Receptor Cell Therapy Sales Volume by Application (2018-2023)
-
Table Central China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Table South China Chimeric Antigen Receptor Cell Therapy Production Volume by Type (2018-2023)
-
Table South China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Figure South China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Table South China Chimeric Antigen Receptor Cell Therapy Sales Volume by Application (2018-2023)
-
Table South China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Figure South China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Table East China Chimeric Antigen Receptor Cell Therapy Production Volume by Type (2018-2023)
-
Table East China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Figure East China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Table East China Chimeric Antigen Receptor Cell Therapy Sales Volume by Application (2018-2023)
-
Table East China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Figure East China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Chimeric Antigen Receptor Cell Therapy Production Volume by Type (2018-2023)
-
Table Northeast China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Chimeric Antigen Receptor Cell Therapy Sales Volume by Application (2018-2023)
-
Table Northeast China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Chimeric Antigen Receptor Cell Therapy Production Volume by Type (2018-2023)
-
Table Southwest China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Chimeric Antigen Receptor Cell Therapy Sales Volume by Application (2018-2023)
-
Table Southwest China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Chimeric Antigen Receptor Cell Therapy Production Volume by Type (2018-2023)
-
Table Northwest China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Chimeric Antigen Receptor Cell Therapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Chimeric Antigen Receptor Cell Therapy Sales Volume by Application (2018-2023)
-
Table Northwest China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Chimeric Antigen Receptor Cell Therapy Sales Volume Share by Application (2018-2023)
-
Table Hebei Senlang Biotechnology Inc Ltd Company Profile
-
Table Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Bellicum Pharmaceuticals Inc Company Profile
-
Table Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Sorrento Therapeutics Inc Company Profile
-
Table Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Beijing Immunochina Medical Science & Technology Co Ltd Company Profile
-
Table Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Celyad SA Company Profile
-
Table Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Cell Medica Ltd Company Profile
-
Table Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Celgene Corp Company Profile
-
Table Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Fosun Pharmaceutical AG Company Profile
-
Table Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Kite Pharma Inc Company Profile
-
Table Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table NantKwest Inc Company Profile
-
Table NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Gilead Sciences Inc Company Profile
-
Table Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Co Company Profile
-
Table Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Juno Therapeutics Inc Company Profile
-
Table Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Celularity Inc Company Profile
-
Table Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Cellular Biomedicine Group Inc Company Profile
-
Table Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Amgen Inc Company Profile
-
Table Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Profile
-
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Nanjing Legend Biotech Co Ltd Company Profile
-
Table Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Nkarta Inc Company Profile
-
Table Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Autolus Therapeutics Plc Company Profile
-
Table Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table HRAIN Biotechnology Co Ltd Company Profile
-
Table HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table bluebird bio Inc Company Profile
-
Table bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Daiichi Sankyo Co Ltd Company Profile
-
Table Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Ono Pharmaceutical Co Ltd Company Profile
-
Table Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
Table Takara Bio Inc Company Profile
-
Table Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Price and Gross (2018-2023)
-
